AzTrials
AzTrials

Acute Respiratory Distress Syndrome (ARDS)NCT07375849

Application of Electrical Impedance Tomography in Evaluating Pulmonary Function Improvement After High Lateral Recumbent Position Therapy in ARDS Patients

A study testing Place the patient in the 90-degree high lateral position., Place the patient in the 30-degree low lateral position. and Place the patient in the 120-degree high lateral position. in people with Acute Respiratory Distress Syndrome (ARDS), run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial investigates the effects of prone positioning versus lateral positioning at different angles (30°, 90°, 120°) on pulmonary function improvement in patients with acute respiratory distress syndrome (ARDS). Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Place the patient in the 90-degree high lateral position., Place the patient in the 30-degree low lateral position. and Place the patient in the 120-degree high lateral position.
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
No sites listed yet
Study dates
1 Jan 2026to 1 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age >= 18 years.
  • Diagnosis of ARDS according to the Berlin Definition (2023 update).
  • Clinically evaluated as suitable for positional therapy by physicians.
  • Signed informed consent obtained from the patient or legal representative.
  • Absence of severe spinal deformities or musculoskeletal disorders that may compromise safe high lateral positioning.
  • No severe skin conditions (e.g., extensive open wounds or pressure ulcers) that may affect the feasibility of lateral positioning.

Who cannot join

  • Pregnant or lactating women.
  • Severe cardiac diseases (e.g., unstable arrhythmia or heart failure) that may worsen with positional changes.
  • Severe coagulation disorders with increased bleeding risk.
  • Known allergy to the EIT device or any of its components.
  • Severe psychiatric disorders impairing study compliance.
  • Current participation in experimental therapies that may affect pulmonary function.
  • Severe active infections requiring special isolation measures.
  • Anticipated need for emergency surgery or life-threatening complications within 24 hours.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

This randomized controlled trial investigates the effects of prone positioning versus lateral positioning at different angles (30°, 90°, 120°) on pulmonary function improvement in patients with acute respiratory distress syndrome (ARDS). Utilizing electrical impedance tomography (EIT) technology, the study monitors key parameters including ventilation distribution and ventilation-perfusion matching in real time, while integrating respiratory mechanics and blood gas analysis data to comprehensively evaluate the therapeutic efficacy of positional adjustments. The study hypothesizes that high-angle lateral positioning may reduce adverse complications associated with prone positioning while effectively improving oxygenation and pulmonary function. The ultimate objective is to provide a safer and more personalized positional therapy regimen for clinical practice, optimizing ARDS treatment strategies to reduce mortality and enhance patient survival outcomes.

Being tested
Place the patient in the 90-degree high lateral position., Place the patient in the 30-degree low lateral position., Place the patient in the 120-degree high lateral position., Patients will be placed in the prone position, i.e., lying face down.
Medical subject headings
Respiratory Distress Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Place the patient in the 90-degree high lateral position.Procedure or surgery

    For the 90° lateral recumbent position group, patients will be rotated between corresponding lateral recumbent positions on the left and right sides every 2 hours, spending 8 hours on each side for a total treatment duration of 16 hours. During each rotation, the nursing team will ensure the patient is safely transferred from one side to the other while maintaining the prescribed lateral angle. Wedge pillows or specialized turning pads will be used to assist in positioning, with supports placed beneath the patient's back and buttocks to alleviate pressure points.

  • Place the patient in the 30-degree low lateral position.Procedure or surgery

    For the 30° lateral recumbent position group, patients will be rotated between left and right lateral recumbent positions at the corresponding angles every 2 hours, spending 8 hours on each side for a total treatment duration of 16 hours. During each rotation, the nursing team will ensure the patient is safely transferred from one side to the other while maintaining the prescribed lateral angle. Wedge pillows or specialized turning pads will be used to assist in positioning, with supports placed beneath the patient's back and buttocks to alleviate pressure points.

    Translated with DeepL.com (free version)

  • Place the patient in the 120-degree high lateral position.Procedure or surgery

    For the 120° lateral recumbent position group, patients will be rotated between corresponding lateral recumbent positions on the left and right sides every 2 hours, spending 8 hours on each side for a total treatment duration of 16 hours. During each rotation, the nursing team will ensure the patient is safely transferred from one side to the other while maintaining the prescribed lateral angle. Wedge pillows or specialized turning pads will be used to assist in positioning, with supports placed under the patient's back and buttocks to alleviate pressure points.

    Translated with DeepL.com (free version)

  • Patients will be placed in the prone position, i.e., lying face down.Procedure or surgery

    Patients will be positioned in the prone position, lying face down, with specialized prone positioning devices or pillows supporting the head and chest to ensure airway patency. Daily prone therapy duration is set according to clinical guidelines, typically lasting 16 hours.

Study groups in NCT07375849
Study groupRoleWhat they receive
90-degree high lateral position groupExperimentalPlace the patient in the 90-degree high lateral position.
Receives: Procedure: Place the patient in the 90-degree high lateral position.
30-degree low lateral position groupExperimentalPlace the patient in the 30-degree low lateral position.
Receives: Procedure: Place the patient in the 30-degree low lateral position.
120-degree high lateral position groupExperimentalPlace the patient in the 120-degree high lateral position.
Receives: Procedure: Place the patient in the 120-degree high lateral position.
Prone position groupActive comparatorPatients will be placed in the prone position, i.e., lying face down.
Receives: Procedure: Patients will be placed in the prone position, i.e., lying face down.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. death

    Measured: One month after treatment

Secondary outcomes (4)
  1. A/P Ratio

    Measured: 24 hours before treatment, 24 hours after treatment

  2. Ventilation-Perfusion Ratio

    Measured: 24 hours before treatment, 24 hours after treatment

  3. Oxygenation index

    Measured: 24 hours before treatment, 24 hours after treatment

  4. Global Inhomogeneity Index, GI

    Measured: 24 hours before treatment, 24 hours after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2026
  2. Study start1 Jan 2026 (estimated)
  3. Primary completion1 Dec 2027 (estimated)
  4. Study completion1 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07375849
Sponsor's protocol ID
KY-2025-143
Status last verified
Jan 2026
First submitted
22 Jan 2026
Last updated
29 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Place the patient in the 90-degree high lateral position., Place the patient in the 30-degree low lateral position. and Place the patient in the 120-degree high lateral position. in people with Acute Respiratory Distress Syndrome (ARDS), run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lijun Song (+8615869252244, lijun-song@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

death (time frame: One month after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in